Professor
Department of Internal Medicine, Comprehensive Cancer Center
steven.clinton@osumc.edu
(614) 293-2886
Website
Dr. Clinton is a medical oncologist specializing in prostate cancer. He serve as a professor in the Division of Medical Oncology and Department of Urology at The Ohio State University, and holds the Robert A. and Martha O. Schoenlaub Cancer Research Chair. His expertise encompasses the full range of prostate cancer care, from prevention and screening to active surveillance, clinically localized disease and advanced metastatic disease. This effort is the result of seamless interactions among specialized physicians in oncology, urology, pathology and radiation therapy so that our care programs are personalized for each individual.
Dr. Clinton is very proud to offer a weekly Prostate Cancer Multidisciplinary Clinic where men with a newly diagnosed prostate cancer can receive a comprehensive evaluation and detailed review of treatment options in one afternoon visit. State-of-the-art treatment plans ranging from surgery to radiation therapy to medical oncology, as well as integrated combinations, are offered to ensure the greatest chance of cure and quality survivorship.
His team provides opportunities for men to participate in novel and exciting clinical trials in such areas as nutrition, cancer prevention survivorship and therapeutics, including those involving new combinations of pharmaceuticals and radiation, immune therapeutics and targeted agents. His group has established a Prostate Cancer Genetics Clinic to better serve our patients and their families.
In addition to his clinical work, he serve as co-leader of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research is dedicated to prostate cancer prevention and therapy, as well as projects focusing on diet, nutrition and lifestyle for cancer prevention and survivorship.
His lab team has expertise in molecular biology, cellular and experimental models of carcinogenesis, and human clinical trials. One area of his research emphasizes the impact of dietary patterns, specific foods and nutrients on prostate cancer risk. These studies are often conducted in collaboration with scientists in other disciplines at Ohio State, such as food science and agriculture, in a coordinated “crops to the clinic” research effort.
His lab program has published extensively on the role of dietary energy balance and obesity in cancer risk. It also has published studies relating to foods associated with cancer prevention properties, such as hops, tomatoes, soy and cruciferous vegetables, as well as several nutrients, including vitamin D, calcium, omega-3 fatty acids and vitamin E. This work has appeared in such scientific journals as Journal of Nutrition, Molecular Nutrition and Food Research, Clinical Cancer Research, Proceedings of the National Academy of Sciences of the USA, Clinical and Translational Gastroenterology, and Scientific Reports.
He also serves as co-director of Ohio State’s Foods for Health Discovery Theme, a campus-wide effort in food, nutrition and health, as well as on the World Cancer Research Fund effort to define guidelines for cancer prevention that are employed by many organizations, such as the World Health Organization, to impact healthy food and agriculture policies for nations around the globe.
He was named to the Castle Connolly list of “America’s Top Doctors” from 2008-2019 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017.
Return to People